Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
19 October 2006Website:
http://www.lemaitre.comNext earnings report:
01 August 2024Last dividends:
15 May 2024Next dividends:
N/APrice
after hours | Wed, 03 Jul 2024 17:01:29 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
LMAT Latest News
LeMaitre is a long-term compounder with mouth-watering economics and shareholder-friendly management. LMAT shares have rallied 45% since August '23, with increased dividends and improving fundamentals. Management has lengthened the reinvestment runway to deploy funds into the business at an advantage to drive further growth in corporate value.
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LeMaitre (LMAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LeMaitre Vascular, Inc. (NASDAQ: LMAT) will be holding its Q1 2024 Earnings Conference Call on May 2, 2024 at 5:00 PM ET. The company's Chief Financial Officer, Chief Executive Officer, and President will be in attendance. Conference call participants include analysts from Stifel, Oppenheimer, Citizens JMP, Jefferies, and KeyBanc. The operator greets all participants.
LeMaitre Vascular (LMAT) reported quarterly earnings of $0.44 per share, surpassing the Zacks Consensus Estimate of $0.39 per share. This is an increase from earnings of $0.27 per share in the same quarter last year.
BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:30 AM ET.
TOL, WILYY and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 7, 2023.
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 1(current)
- 2
What type of business is LeMaitre Vascular?
LeMaitre Vascular, Inc. is a medical equipment manufacturing company in the United States. Its products are used by vascular surgeons and specialist physicians in invasive procedures. The company offers angioscopes, fiber-optic catheters used for viewing the lumen of blood vessels; embolic catheters for removing clots from arteries or veins; occlusion catheters that temporarily block blood flow; perfusion catheters for temporary blood and other fluid perfusion into the vascular system; and thrombectomy catheters equipped with a silicone balloon for removing clots in the venous system. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
What sector is LeMaitre Vascular in?
LeMaitre Vascular is in the Healthcare sector
What industry is LeMaitre Vascular in?
LeMaitre Vascular is in the Medical Instruments & Supplies industry
What country is LeMaitre Vascular from?
LeMaitre Vascular is headquartered in United States
When did LeMaitre Vascular go public?
LeMaitre Vascular initial public offering (IPO) was on 19 October 2006
What is LeMaitre Vascular website?
https://www.lemaitre.com
Is LeMaitre Vascular in the S&P 500?
No, LeMaitre Vascular is not included in the S&P 500 index
Is LeMaitre Vascular in the NASDAQ 100?
No, LeMaitre Vascular is not included in the NASDAQ 100 index
Is LeMaitre Vascular in the Dow Jones?
No, LeMaitre Vascular is not included in the Dow Jones index
When does LeMaitre Vascular report earnings?
The next expected earnings date for LeMaitre Vascular is 01 August 2024